ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0009790;embryo development;4.0;0.7980440201809971;0.6490220100904985;9.040737587590003;21.10990084630072;4.5143834387755835;7.065293836483571E-4;0.4808657789992824;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PDGFC, PLCG1, MYH10, TGFB2, STIL, EIF2S2, BMP2, MAFF, PTPRR, BRCA1, TMEM100, HHEX, EDN1, TIE1]
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[SPARC, SERPINE1, FASLG, PRL, HHEX, STAB1, EMILIN1, HOXA5, CCR2, SEMA6A, HSPG2, DCN, COL4A2, HGS, CX3CR1, THBS2, THBS1, E2F2, TGFB2, PLK2, TIE1, KLF4, SULF1, PML, CXCL10, TEK, PF4]
GO:0061333;renal tubule morphogenesis;6.0;0.7192862368539868;0.682763431017138;8.801845679307654;32.20947323359611;6.943860283624253;0.0010780220824845236;0.6782296504172152;[MEF2C, COL4A1, TACSTD2, HNF1B, LGR4]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, GATA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, KITLG, SFRP2, NASP, MSH2, KIT]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, THBS1, CLDN4, FOSB, TLR2]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, SLA2, FGF5, IMPA2, PDGFRB, PDGFRA, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, PDGFA, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, CD28]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, IL10, GHSR, ANXA1, ANXA3, GAB1, SIRT1, F3, GREM1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TOP2A, SPI1, TNFRSF13B, SOX4, PDGFRA, ESCO2, KIT, HOXB4, HOXB3, PLD4, GATA3, JAM3, TGFB1, ACE, INHBA, PTPRC, PTPN6]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0030823;regulation of cGMP metabolic process;9.0;0.7586651285174919;0.775573189439035;9.392135474427892;212.55514157362143;6.444869117505266;0.00711402930126111;0.7258315315665724;[PDE5A, GUCA1C, THBS1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, FOS, SIRT1, MMP12, CKS2, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, FHL2, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, IL10, RGMA, IL1B, YAP1, SATB2, CD74, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, RARA, ENG, EPCAM, NR1H2, GTF2H1, POU4F1, FOSB, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, BCL3, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPB, SMARCD3, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, MDFIC, TFEC, TLR4, TLR2, CDX2, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKAP2, DCN, DNM2, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, PTPRR, TMEM100, HHEX, EDN1, TIE1]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[CD40, ITGA4, FASLG, THBS1, CD40LG, CCL2, PLCG1]
GO:2001205;negative regulation of osteoclast development;10.0;1.0;0.9152410118609203;9.628524252492122;1250.359070569308;8.16763571524637;0.041848392841848644;0.8329342821725234;[LILRB1, LTF, FBN1]
GO:0034504;protein localization to nucleus;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.77360880529348;4.8942717050940985;0.001096903192380182;0.5734135951955668;[NUP107, CSE1L, HHEX, XPO1, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, PLK1, RANBP6, PML, COL1A1, NUP35, RAN]
GO:0019800;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;9.0;1.0;0.896240625180289;9.628524252492122;433.4643727638907;7.9853141584524145;0.014507662463798891;0.8046099625986299;[SPOCK3, BGN, DCN]
GO:2000491;positive regulation of hepatic stellate cell activation;6.0;1.0;0.8231203125901445;9.628524252492122;58.82470762909909;8.390779266560578;0.001968810025546158;0.7522251544931926;[PDGFRB, MYB, RPS6KA1]
GO:0036120;cellular response to platelet-derived growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.781341354126479;0.003262744749111514;0.6699184248047958;[PDGFRB, CCNA2, PDGFD, FYN]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[PDGFRB, NRP1, PDGFRA, PDGFA, NR4A3, PDGFD, PDGFC]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, GATA1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[CELSR1, ARHGAP6, ARHGAP4, EPS8, PAK1, ARHGDIA, PDPN, ARHGDIB, RAC2, EPS8L1, EPS8L3, ARHGEF12, CHUK, RHOG, RHOH, COL1A2, BCL6, AGTR1, RHOU]
GO:0051895;negative regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;270.76229412472316;7.069023426578259;0.009062170314110184;0.7365101867784198;[DLC1, ARHGAP6, THBS1]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[CSF1R, PTAFR, GATA3, AKT1, KCNH1, PDGFRB, PDGFRA, EDN1, GSN]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[SPARC, SPINT2, AKT1, PDGFRB, MEF2C, POSTN, RUNX2, SPINT1, COL4A2, CALCA, TWIST1, GATA3, ADAMTS12, EPB41L5, PDGFD, PLCG1, TGFB1, EGR3, VCAM1, CAV1, COL1A1, NR4A1, BMP2, ID1, NOX4, SNAI2, FBN1, NRP1, MCM7, TMEM100, IL10, EDN1, ANXA1, ARG1, CAD, TNFRSF1B, PAX2, CCNA2, XCL1, GAS1, CX3CR1, DTYMK, THBS1, CCL5, E2F1, CCL2, FYN, SNCA, MAPK14, KLF4]
GO:0045780;positive regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;82.90338698468558;6.943860283624253;0.002774701754173115;0.7060287030842711;[TFRC, SYK, SPP1, TNFSF11, TNFRSF11A, TMEM64]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB2, EPHB1, AP2M1, MMP2, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[MCM7, AKT1, PLCG1, CAD, PAX2, COL1A1, ID1, SNAI2]
GO:0010544;negative regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.593432932680852;379.9001511686048;6.8867018697843045;0.012714916171674395;0.7484268790654467;[PDGFRA, THBD, CEACAM1, PRKCD, CD9, PDGFA]
GO:0018146;keratan sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;415.40755540718914;6.409777797693995;0.013903317036950667;0.7027963346592216;[LUM, OMD, OGN, ST3GAL6]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[DSP, ANXA1, EPB42, FN1, BGN, F13A1, THBS1, DCN, COL3A1, SPOCK3]
GO:2000249;regulation of actin cytoskeleton reorganization;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;36.19570401534177;6.221725566191056;0.0012114376393747596;0.6931793347948383;[NRP1, PDGFRA, CSF1R, TGFB1, F11R, HCK, FES, ARHGDIA, NTF3, ARHGDIB, STAP1, TEK]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[TNFAIP3, PTPRK, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, ANXA1, CHUK, ARG1, TPM1, PRKCD, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, BTK, PCNA, FOXO1, CST3, PDGFD, ECT2, JUN, KLF4, IL6, CDK1, EZH2]
GO:0034976;response to endoplasmic reticulum stress;4.0;0.6799073451904818;0.5899536725952409;8.284789505791027;28.997869804256865;4.300610075748959;9.705326059599744E-4;0.4699333992726228;[TLN1, ATF3, JUN, WFS1, TNFRSF10B, EIF2S1, FKBP14, PPP1R15A, CEBPB, THBS1, CCL2, PML, PSMC6, PSMC2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, IGFBP5, GAB1, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, PDGFA, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0035025;positive regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;339.6245583269611;6.481236761676141;0.01136692832494487;0.7466917612613706;[PDGFRB, F2R, COL3A1, GPR18, F2RL3]
GO:0006024;glycosaminoglycan biosynthetic process;6.0;0.7586651285174919;0.7024528768488905;9.158520623246385;237.49504005673018;5.16195311083921;0.007948745259039342;0.5871028347338303;[SDC2, NDST3, ST3GAL6, PDGFRB, HS3ST3B1, LUM, OMD, BGN, HSPG2, DCN, VCAN, IL1B, OGN, SDC1, CSPG4]
GO:0002581;negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;55.710237364246;8.67846133901236;0.0018645715086227877;0.7669372290569613;[HLA-DOA, HLA-DOB, THBS1]
GO:0038091;positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;112.44183520208205;8.67846133901236;0.0037633270331318856;0.8590579283277371;[PDGFRB, PDGFRA]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, F13A1, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, STXBP2, PDGFA, THBS1, PSAP, FLNA, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, SELP, TF, CD9, PF4]
GO:0071394;cellular response to testosterone stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;389.00028322827603;7.697632086000634;0.01301948940212445;0.7167775754447168;[SPP1]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MEF2C, MAP2K2, PAQR3, EREG, BTC, PDGFA, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, GFRA3, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, CDH17, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, THBS1, HMOX1, LYN, EIF2S1, CXCL10, TFEC]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[CXCR5, TGFA, PDGFA, AURKB, FGF5, LBH, RACGAP1, PDGFD, NUP62, PDGFC, ECT2, SVIL, TGFB2, TGFB1, PRKCE, TAS2R13, CDC6, PPBP, CIT, EREG, BTC, IL1B]
GO:0010757;negative regulation of plasminogen activation;10.0;1.0;0.9152410118609203;9.628524252492122;820.5340776865997;7.9853141584524145;0.027462537147443688;0.8236103492792612;[CTSZ, SERPINE1, THBS1]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, PML, EREG, BTC, CCNA2, NDUFS4]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, IFNGR1, BGN, FOS, SIRT1, F3, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB2, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL1, BIRC5, LCP1, CX3CR1, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, PML, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, TNFSF11, RSAD2, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, CD74, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, VCAM1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, CAMK2D, SAMHD1, NCAM1, CD4, LTBR]
GO:0003429;growth plate cartilage chondrocyte morphogenesis;8.0;1.0;0.875;9.628524252492122;76.28302296905001;6.8867018697843045;0.002553124128510584;0.7271862538851576;[COL14A1, COL6A2, COL12A1, COL6A1, COL6A3]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1, MAPK14, THBS1]
GO:0010754;negative regulation of cGMP-mediated signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;9.777073627680469;0.008005804360164796;0.875;[THBS1]
GO:2000379;positive regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;112.71770282919289;5.299736813202263;0.0037725600743465397;0.5941490996802742;[CDKN1A, PID1, ITGAM, ITGB2, TNF, CLU, AKT1, CD36, CD177, PDGFRB, EDN1, PRKCD, DNM2, IFNG, IL1B, AGTR1, TLR6, TLR4, FPR2, PTGS2, THBS1, GNAI2, KLRK1, SNCA, TGFB1, AGXT2, MAPK14, KLF4, NOX4, PTX3]
GO:2001223;negative regulation of neuron migration;8.0;0.8933024483968273;0.8216512241984136;9.59462270081644;537.8957402660368;7.379178354882098;0.018002886351966806;0.7523715242355574;[COL3A1]
GO:0010751;negative regulation of nitric oxide mediated signal transduction;8.0;1.0;0.875;9.628524252492122;239.1998693179246;8.67846133901236;0.008005804360164796;0.8188169164668168;[THBS1]
GO:0008210;estrogen metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;78.56989776551285;6.599019797332524;0.002629663769894499;0.6605944919115335;[PDGFRA, HSD17B4, CYP1B1]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[MMP1, MMP2, HTRA1, LAMC1, MMP8, MMP9, CTSS, MMP12, TIMP2, MMP19, CTSG, TIMP1, LCP1, ELANE]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[POSTN, EGR3, COL1A1, NR4A1, CCL5, CCL2, SNCA]
GO:0048701;embryonic cranial skeleton morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;46.18089108149027;6.280566066213989;0.0015456328643938164;0.6443087532925187;[PDGFRA, PRRX1, TWIST1, PAX5, GRHL2, RUNX2]
GO:0006710;androgen catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;238.91733116815087;8.390779266560578;0.007996348062559696;0.7800242071602487;[SPP1]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:1990314;cellular response to insulin-like growth factor stimulus;8.0;1.0;0.875;9.628524252492122;388.66587636398185;7.57984905034425;0.013008297105323164;0.7626338329336335;[CCNA2, GHSR, TGFB1, FBN1]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[NRP1, SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, TNF, LGALS3, AKT1, DAPK1, SFRP2, IL1B, CX3CR1, YAP1, IFI6, THBS1, GATA1, CTNNA1, HMOX1, FYN, TNFRSF10B, SNAI2, PF4]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, CEACAM5, KIT, PECAM1, XCL1, CEACAM8, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0010763;positive regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;201.49065414776382;7.379178354882098;0.006743710864509851;0.7523715242355574;[PAK1, TGFB1, PRKCE, AKT1, THBS1, SLC8A1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, MSH2, IFNG, GAS1, PPP1R15A, CUL5, THBS1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, PML, FAP, JMY]
GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1143.6879814690685;7.212124270218933;0.03827820748741112;0.8169486831672182;[GREM1, EGF, PDGFC, ADRB2]
GO:0040037;negative regulation of fibroblast growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;298.26786127592857;7.004484905440688;0.00998275689325772;0.7091290490632969;[GATA3, SULF1, THBS1, SULF2]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, THBS1, CCL5, IL6, LIN28A, BCL3, CD28, EIF3E, EIF3D]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[ITGB5, PTPRK, F11R, CDH5, FOS, SIRT1, TGFBR3, ADAM9, JUN, TGFB2, TGFB1, USP9Y, PTK2, PML, COL3A1, COL1A2, ID1, ZYX]
GO:0048557;embryonic digestive tract morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;31.256231937100466;6.832634648514029;0.0010461179541522844;0.639662265535933;[PDGFRA, IHH, HNF1B]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[CDCA5, TGFA, PHB2, NUP62, SH2B1, PDGFRB, RANBP2, RANBP1, EDN1, TGFB1, EGF, UBE2C, EREG, BTC, IL1B, CD28]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, IL10, ANXA1, FCER1G, SYK, RHOG, GAB1, VAV1, IL1B, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0031954;positive regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;6.481236761676141;0.026061291479152104;0.7466917612613706;[ACE, SYK, PDGFA, GREM1, RAD50, GPNMB, PDGFD, PDGFC]
GO:0006518;peptide metabolic process;5.0;0.5557027117453593;0.5680923677336;7.651361559932704;56.97144087449193;3.860871565073034;0.001906782855101251;0.48768616324764424;[ANPEP, AKT1, ENPEP, MGST1, ELANE, ACE, CTSZ, PCSK6, CTSH, CTSG, MME, DMD, APEH, LAMP2, PSEN2, AEBP1, TRHDE, COPS5, EEF1G, HM13, EIF4H, NDUFA7]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[FSTL1, TMEM100, EGR1, TGFB2, TGFB1, USP9Y, RUNX2, RGMA, TGFBR3, BMP2, ID1, ENG]
GO:0048685;negative regulation of collateral sprouting of intact axon in response to injury;12.0;1.0;0.9481203125901445;9.628524252492122;2501.984454668437;9.777073627680469;0.08373916805793223;0.9481203125901445;[SPP1]
GO:0042340;keratan sulfate catabolic process;8.0;1.0;0.875;9.628524252492122;411.1022627208988;7.292166977892469;0.013759222765252392;0.747921758369865;[LUM, OGN, OMD, GNS]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[THBS1, PLN, SPP1, EDN1, DUSP1, CAD, NME1, NASP]
GO:0051965;positive regulation of synapse assembly;7.0;0.8259837884571596;0.7639112594857803;9.437469015729413;224.643362448917;5.602686357784832;0.007518611175264769;0.6374410061458773;[NLGN1, AMIGO3, LRRN3, THBS2, FLRT2, SLITRK6, EPHB2, EPHB1]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, EDN1, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, APLP2, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, ARHGEF12, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0060437;lung growth;4.0;1.0;0.75;9.628524252492122;24.192359555962447;8.67846133901236;8.096965026280019E-4;0.6938169164668168;[PDGFRB]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, SPARC, CTGF, EDNRB, AKT1, PRKACB, MEN1, GHSR, LHCGR, IGFBP5, PRKCD, EREG, POR, ADCY9, PRKAR1B, ABCB4, SLC30A10, FOXO1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, FBN1, ADM, HHEX, TIMP1, IL10, EDN1, ANXA1, ARG1, GLP2R, CAD, SIRT1, TGFBR3, CCNA2, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, SORBS1, TSHR, TEK]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MEF2C, HNF1B, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, BMP2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, GREM1, ELF3, RARA, YAP1, TAGLN, CEBPB, PCNA, E2F7, CDX2, KLF4, USH2A, GRHL2]
GO:0032914;positive regulation of transforming growth factor beta1 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.62186638127122;7.9853141584524145;0.0028656868131042177;0.7592887026755414;[LUM, THBS1]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, EPB41L5, PDGFD, FYN, MEF2C, EDN1, POSTN, TGFB1, ARG1, CAV1, COL1A1, COL4A2, NOX4, XCL1, FBN1]
GO:0002605;negative regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.710237364246;9.083926447120524;0.0018645715086227877;0.7876727335416686;[FCGR2B, THBS1]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, CTGF, RUVBL2, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[LAMB3, ITGB5, ITGA4, COL11A1, MMP2, LAMA3, COL12A1, ITGB2, FN1, LAMB1, INHBA, MMP8, MMP9, COL4A2, COL6A1, COL8A1, ITGA7]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, EPHB2, PHLDA2, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IL10, EDN1, GREM1, IFNG, IL1B, LTA, XCL1, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0033327;Leydig cell differentiation;4.0;1.0;0.75;9.628524252492122;40.68519770516384;7.379178354882098;0.0013616969528911006;0.6273715242355574;[PDGFRA, MGST1]
GO:0006986;response to unfolded protein;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;23.958124258549983;5.75172193694532;8.018568580216882E-4;0.5843843391987277;[THBS1, HSPD1, HSPE1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[LGALS1, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FSTL1, CST3, SPP1, PSMC6, PSMC2, NUCB1, TNC, MEN1, IGFBP5, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, LAMB1]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[CEBPB, ABCB4, TNF, PDGFD, PDGFC, FYN, PDGFRA, MMP2, COL1A1, COL3A1, COL1A2, COL4A1, COL5A2, COL6A1]
GO:2000739;regulation of mesenchymal stem cell differentiation;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;28.839904850249063;7.9853141584524145;9.652456611085622E-4;0.7314896500084853;[PDGFRA, LTBP3]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[IL10, JUN, IGFBP5, MMP2, MMP9, TNF, GNAI2, PAK1, NR4A3]
GO:2001027;negative regulation of endothelial cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;484.3135532944439;8.390779266560578;0.016209538774865105;0.8443458537639685;[CXCL13, THBS1]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, BRCA1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, DOCK4, POSTN, IGFBP5, P2RY6, PAK1, NR4A3, CCL5, PDGFD, NOX4]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[IFNA2, TNFAIP3, TNF, LGALS3, DUSP10, DHX58, CTLA4, IL13RA2, CCR2, HAVCR2, IL10, CD96, CR1, ANXA1, ARG1, SERPINB9, IRAK3, MMP12, ADCYAP1, CEACAM1, XCL1, SERPING1, CLEC12B, INPP5D, HMOX1, LYN, TGFB2, TGFB1, NR1H2, LILRB1, COL3A1, PTPRC, BCL6, PTPN6, FCGR2B]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MEF2C, CXADR, PRKCE, PRKCD, SERPING1, PRKCQ, HHLA2, FPR1, FPR3, FPR2, GATA3, THY1, KLRK1, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, HLA-DPA1, HAVCR2, ANXA1, ARG1, IFNGR1, FCRL3, NFAM1, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, RARA, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, ADCYAP1, CLEC4D, MSH2, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, TREM2, PTPN22, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, UNC93B1, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, ICAM2, ICAM3, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, MIF, EREG, IL23A, BTK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, PAG1, SH2D1A, TNFSF13, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, PAK1, IGKC, NPDC1, CD74, LILRB1, LILRB2, MLH1, CD40LG, CD86, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, OSCAR, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, KIR2DL4, STAP1, NLRP3, TGFB2, TGFB1, VCAM1, CAV1, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, TRAT1, MAPK14, CD4]
GO:0007043;cell-cell junction assembly;5.0;0.7508913569872202;0.6656866903545304;8.817594036275793;53.94372379865016;5.16195311083921;0.0018054478893412883;0.554223534004606;[F11R, GJC1, CDH5, CDH3, CDH1, EPB41L3, CTNNA1, ECT2, JUP, LSR, ACTN4, GRHL2, GJB2, CLDN3, CDH11, CD9, PKP3, TLN1, CDH17, VCL]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[IL1RN, CELSR1, HNF4A, PHLDA2, PRKACB, IL10, HNF1B, DUSP6, SFRP2, LAMA4, LAMA3, GATA3, DLL1, GATA1, RACGAP1, FZD1, CDX2, KLF4, SULF1, COL5A1, COL5A2, CDK1, FOXA2]
GO:0061304;retinal blood vessel morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;25.965694757875163;8.16763571524637;8.690484359379531E-4;0.7079342821725234;[COL4A1, CYP1B1]
GO:2000866;positive regulation of estradiol secretion;9.0;1.0;0.896240625180289;9.628524252492122;439.69537685412286;8.67846133901236;0.014716208563159352;0.8400575416471059;[IL1B, SPP1]
GO:0045089;positive regulation of innate immune response;7.0;0.5408746917014966;0.6213567111079488;7.77894521237524;173.7808589209889;4.201124524534153;0.005816288955466338;0.5657650688141469;[CLEC10A, ICAM2, ICAM3, PYCARD, IL18RAP, DHX58, PRKACB, LAG3, RSAD2, PRKCE, CD180, PRKCD, EREG, CLEC4D, BTK, S100A8, CARD11, LY96, CD1D, DDX60, KLRK1, CLEC7A, S100A14, CD14, MAP2K6, LYN, CAV1, SH2D1A, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, HMGB2, TNFAIP3, PTPN22, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, DDX58, MMP2, IRAK3, VAV1, MMP12, TLR1, HCK, IRF7, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, LTF, TLR2, COLEC12, UNC93B1, NLRC4, NOD2, HSPD1, PAK1, CCL5, FYN, CARD9]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, UQCRC1, PRKCQ, UQCRC2, ENPEP, GATA3, ADAMTS12, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, FBXW2, CDC25A, ADAM2, ADAM9, ADAM7, CUL5, AEBP1, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, ADAMTS1, ADAMTS20, ASPH, DTL, HM13, FGL2, RNF24, PML, EIF3F, CDC20, ANPEP, SKP2, CFTR, CTSZ, BRCA1, PCSK6, CTSS, CTSH, CTSG, CTSB, MME, RNF144B, C1QB, C1QA, CD5L, IGKC, PERP, RANBP2, RANBP1, FAP, MAD2L1, IHH, BUB1B, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, TGFB1, UBE2C, NFKBIA, IGKV3-20, TNFAIP3, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, AURKB, NRIP3, RBMX]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, LILRB1, IRAK3, THBS1, NFKB1, TLR8]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[PDGFA, CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, SIRT1, PTK2, DCN, FGR, SELP, GH1, KIT, CD28, PTPN6, TEK]
GO:0021957;corticospinal tract morphogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;69.80210411808247;8.390779266560578;0.002336213607016992;0.8615337942327104;[CDH11]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, GATA3, LYN, ABCA1, COL1A1, MMP12, CENPF, GOPC, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, TNFSF13B, ITGB6, LCP2, LRP1, LRP2, GOLPH3L, HNF1B, ACTN4, MSR1, EGR2, POLA2, TF, CD24, CD3G, AKAP12, CCR7, CD36, SYK, HSD17B4, STX11, CD74, FKBP1B, RAMP1, SCARB2, CARD11, ECT2, NUP155, NASP, NUP62, YWHAH, NUP133, TBC1D9, CHI3L1, NUP54, NUP35, RAN, PHB2, HOMER3, CUBN, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, CCL19, TNF, CLU, LAMP2, RAB32, CALCRL, SLC15A3, BCL6, BCL3, CCDC22, NLGN1, UNC93B1, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0046697;decidualization;4.0;1.0;0.75;9.628524252492122;34.68251427445171;6.781341354126479;0.0011607925405295219;0.5967981122146513;[GHSR, VDR, LIF, SPP1, PTGS2, MEN1, CTSB]
GO:0090051;negative regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;662.774530299232;7.069023426578259;0.02218246707076338;0.7939391391080821;[KLF4, THBS1]
GO:0042535;positive regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;857.3444905607055;7.379178354882098;0.028694548539119222;0.7523715242355574;[TLR1, AZU1, TLR4, THBS1, CCR2]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, AQP1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, NOX4, CD24, ALAS2, SUV39H1, ADM, ALAD, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, TEK]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, TGFB1, MYB, F2R, IHH, ENG, CTGF]
GO:0010812;negative regulation of cell-substrate adhesion;6.0;0.7980440201809971;0.722142322680643;9.117698628726131;52.01138116012746;5.769740442447999;0.001740774120225403;0.618185107137305;[SERPINE1, TACSTD2, FBLN1, ARHGAP6, THBS1, LGALS1, HOXA7, MEN1, POSTN, JAG1, ACTN4, COL1A1, BCL6, DLC1]
GO:0010811;positive regulation of cell-substrate adhesion;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;35.30989762708448;5.049685808968129;0.0011817904967337807;0.5484821789659555;[DOCK5, NRP1, CYR61, EMILIN2, CCR7, EMILIN1, CD36, PRKCE, OLFM4, DNM2, CCDC80, MMRN1, CEACAM6, NINJ1, COL8A1, THY1, NID1, EPB41L5, FLNA, JUP, CCL21, FN1, TEK]
GO:0070208;protein heterotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;7.212124270218933;0.002859955186148837;0.7197477358342742;[COL1A1, COL1A2, COL6A2, NUP62, COL6A1, NUP54]
GO:1902043;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;424.7653704329427;6.943860283624253;0.014216514684375884;0.7703503496879909;[MAL, TIMP3, THBS1, ATF3]
GO:0035793;positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;462.90611455550015;8.67846133901236;0.015493051065716704;0.8762458687964789;[PDGFRB, PDGFA]
GO:0016239;positive regulation of macroautophagy;8.0;0.7671156992804218;0.7585578496402109;9.242861771680136;266.06548500403863;5.666199763507158;0.008904972339694651;0.6647697194109919;[ADRB2, HMOX1, TSC2, SIRT1, DCN]
GO:0035790;platelet-derived growth factor receptor-alpha signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.533214072687796;32.10089673219906;9.777073627680469;0.0010743881246952718;0.896240625180289;[PDGFRA]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, IHH, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, CDH1, MEF2C, ACTN1, COL23A1, CLDN3, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, BCL6, ID1, NOX4, NRP1, COL14A1, ITGB3, LAMC1, ITGB7, ITGA4, GP1BA, GREM1, PALLD, COL6A2, CDH11, COL6A1, COL6A3, CDH17, YAP1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, KLF4, COL1A1, IL6, NR4A3, FKBP1B, CDK1, SDC1, EZH2]
GO:0032836;glomerular basement membrane development;5.0;0.8933024483968273;0.736892236059334;9.405380701177911;30.929431176690045;7.474488534686424;0.0010351802268029372;0.6724867031240476;[SULF1, NID1, SULF2]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[CYFIP1, CELSR1, F11R, CTGF, PYCARD, EPS8, ARHGDIA, STMN1, ARHGDIB, ARFIP1, PDGFRB, TMOD1, PDGFRA, MEF2C, PRKCE, TPM1, PRKCD, PFN1, EPHA3, CSF1R, TACSTD2, PDGFA, CORO1A, SPTA1, STAP1, NCKAP1L, VASP, TGFB1, BST1, CXCL12, FES, JMY, ID1, NOX4, NRP1, LMOD1, ARHGEF10L, ARHGAP6, CCR7, SPTAN1, EDN1, RHOG, RHOH, ARAP1, CIT, HCK, TMEFF2, RHOU, SHANK3, LRP1, SYNPO2, PAK1, NTF3, EPS8L1, FLNA, EPS8L3, JAM3, GSN, CCL21, DLC1, TEK]
GO:0030539;male genitalia development;5.0;1.0;0.7902410118609202;9.628524252492122;66.31594138202881;6.832634648514029;0.002219534877584045;0.639662265535933;[PDGFRA, LHCGR, DHCR24, LGR4]
GO:0035789;metanephric mesenchymal cell migration;7.0;1.0;0.8509193652572005;9.628524252492122;22.41982222863266;9.777073627680469;7.503712734623007E-4;0.8509193652572005;[PDGFRB]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[CTSZ, IHH, PCSK6, CTSS, PLAU, CTSH, CTSG, MME, F3, ASPH, UQCRC1, UQCRC2, ENPEP, HM13, CD5L, PSEN2, AEBP1, PERP, ACE, F11, DHCR24]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, IL1RN, TNF, PROK2, TNFSF11, PDGFRB, MAP2K2, F2R, MIF, ADAM9, C5AR1, FPR1, TGFA, PDGFA, TNFRSF11A, IQGAP3, PDGFD, PDGFC, S100A12, ELANE, DRD4, MAP2K6, TGFB1, FZD5, FZD8, GH1, BMP2, CDK1, NOX4, CSPG4, CD24, EZH2, CD40, LRRK2, GHR, MAP4K1, EDN1, SYK, DUSP6, MDFIC, IL1B, KIT, PDE5A, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CSK, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, RARA, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, BCL3, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPB, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, RGMA, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, LILRB1, GRHL2, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, HTRA1, MAPK14, ASCL2, PTK2, DCN, PHLDA2, E2F7]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IL10, EDN1, IGFBP5, MMP2, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, IL6, NR4A3]
GO:0050730;regulation of peptidyl-tyrosine phosphorylation;9.0;0.6873818243518346;0.7399315373562063;9.0689084645567;111.97076766282173;4.31748811353631;0.003747560826526104;0.6170371680902661;[CD80, PPP2R1A, IL6R, PRKCE, PRKCD, MIF, EREG, SFRP2, IL23A, CSF1R, TGFA, PDGFA, THY1, GATA1, PDGFD, PDGFC, STAP1, LYN, TGFB1, ACE, CAV1, LIF, BST1, GH1, IL6, CSPG4, CD24, NRP1, CD40, ITGB3, IFNA2, ITGB2, TREM2, CD3E, GHR, GRM5, CD36, SYK, GREM1, IFNG, BANK1, KIT, HBEGF, CCL5, NTF3, FYN, CD74, EGF, CD4, PTPN6]
GO:0071670;smooth muscle cell chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;55.63348935964576;9.083926447120524;0.0018620028219775377;0.8154717862087246;[PDGFRB]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, IHH, FHL2, CYR61, FBL, AKT1, MEF2C, TPM4, IGFBP5, IGFBP3, RUNX2, VCAN, COL6A1, EPHA2, HSD17B4, TWIST1, GPNMB, FIGNL1, SPP1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, SNAI2, RBMX, LGR4]
GO:0010596;negative regulation of endothelial cell migration;9.0;0.8436909121759173;0.8180860812682478;9.533214072687796;299.55593944109387;5.905872616772578;0.010025867710250715;0.6982672254532021;[MEF2C, TGFB1, JUP, NR2F2, CXCL13, KLF4, THBS1, DCN]
GO:0048545;response to steroid hormone;5.0;0.6913464685778243;0.6359142461498324;8.935377071932177;60.25199573142884;4.388001897863968;0.0020165800738552384;0.51464363298064;[IL1RN, SPARC, TNF, CTGF, AQP1, GHSR, ADCYAP1, CLDN4, LOX, ADAM9, FECH, ABCB4, FOXO1, IGFBP7, TGFB2, TGFB1, CAV1, COL1A1, IL6, ALPL, SDC1, CDKN1A, GABRB1, HMGB2, ADM, ALAD, IL10, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, IL1B, ACSBG1, ENG, TLR2, YAP1, PCNA, PTGER2, PTAFR, PTGS2, THBS1, SPP1, FOSB]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[NRP1, CD40, PTGS2, THBS1, AKT1, HMOX1, PLCG1, TGFB1, ANXA1, PLK2, SIRT1]
GO:0090280;positive regulation of calcium ion import;9.0;0.8653626801206646;0.8289219652406215;9.420884887713877;92.69484377077161;6.8867018697843045;0.0031024130010644134;0.7484268790654467;[PDGFRB, LGALS3, CXCL12, CCL2]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[ACHE, TAGLN, TWIST1, AEBP1, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, ETV1, SIRT1, CXCL10, CENPF, ITGA7, COL6A3, HBEGF]
GO:1902618;cellular response to fluoride;5.0;1.0;0.7902410118609202;9.628524252492122;70.21110216540774;9.777073627680469;0.0023499024035866234;0.7902410118609202;[COL1A1]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, TNFSF11, TLE4, PCOLCE, SIRT1, PADI2, KLF4, PML, BSPRY, KLF5]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0031960;response to corticosteroid;6.0;0.7140352122741334;0.6801379187272112;9.05316010758856;61.63829009254609;4.689477292448085;0.0020629780985379075;0.5629403994089356;[CDKN1A, IL1RN, SPARC, ADM, TNF, CTGF, AQP1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, ENG, PCNA, FECH, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, COL1A1, IL6, ALPL, SDC1, FOSB]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, SPARC, CD80, SERPINE1, CXCL13, MPO, LOXL1, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, SELP, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, TLR4, CX3CR1, CEBPB, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[TGFB2, COL14A1, LUM, COL11A1, COL12A1, LOXL2, COL1A1, GREM1, COL3A1, SFRP2, COL1A2, COL5A1, LOX, COL5A2, CYP1B1]
GO:0030511;positive regulation of transforming growth factor beta receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;345.4564576873422;6.518977089658987;0.011562116748168153;0.7083807915285978;[MYOCD, TGFB1I1, THBS1, TGFBR3, LRG1, MEN1]
GO:0071306;cellular response to vitamin E;8.0;1.0;0.875;9.628524252492122;314.0784094220964;9.083926447120524;0.010511921711140423;0.839552420951524;[COL1A1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, CSF2RB, MAP2K6, LYN, LIF, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, SYK, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0023019;signal transduction involved in regulation of gene expression;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;6.781341354126479;7.75488093814194E-4;0.6370391240755715;[FGF5, PDGFRA, EPCAM, HNF4A]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA2, GRAP2, AKT1, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, VRK1, MELK, BTK, SIK1, BLK, CSF1R, THY1, LYN, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, CAMK2D, AURKB, PAK1, FYN, CSK, CAMK4, TEK]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[SLC8A1, CTGF, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, THBS1, EGR1, EIF2B3, TGFB1, LIN28A, FKBP1B, NOX4]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[YAP1, TNC, PHB2, AQP1, MYB, CTSH, HOXA2, IGFBP7, LYN, ABCA1, PDGFRB, DUSP1, TIE1, KLF4, PAX2, COL1A1, RARA, EPHA3]
GO:0048048;embryonic eye morphogenesis;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;49.04309196241861;6.686031174322154;0.001641428152064931;0.665044257777226;[EFEMP1, FZD5, MFAP2, IHH, FBN1]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, AQP1, RPS6KA1, AKT1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[IL10, ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:0055003;cardiac myofibril assembly;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;125.46400130584401;6.641579411751319;0.0041991672134361795;0.7146506799819907;[PDGFRB, MEF2A, PDGFRA, MYH10]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, SFRP2, DAAM2, LGR4, NAIP]
GO:0090141;positive regulation of mitochondrial fission;8.0;1.0;0.875;9.628524252492122;158.83836540067767;7.069023426578259;0.005316177144712613;0.7365101867784198;[DCN]
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;57.50475921673876;7.474488534686424;0.0019246325400609058;0.7572456912631272;[COL1A1, SYK, COL4A2, COL4A1]
GO:0046426;negative regulation of JAK-STAT cascade;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;286.97803335492995;5.845247994956144;0.009604896512927369;0.6951668794741764;[LRRC19, CAV1, LRRC4, BGN, GP1BA, PODN, DCN, SOCS2, FLRT2, HGS, PPP2R1A, LRRTM4, BCL3]
GO:0032516;positive regulation of phosphoprotein phosphatase activity;10.0;0.8653626801206646;0.8479223519212526;9.5525383455142;1089.2705050571928;6.832634648514029;0.036456903524454846;0.7646622655359331;[PDGFRB, PPP1R15A, PPP1R12A, FCRL3]
GO:0010748;negative regulation of plasma membrane long-chain fatty acid transport;9.0;1.0;0.896240625180289;9.628524252492122;652.3932031735304;8.390779266560578;0.02183501339445399;0.8253454670833372;[AKT1, THBS1]
GO:0010863;positive regulation of phospholipase C activity;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;83.73920694943958;6.139487467954083;0.0028026758962042993;0.6889736746265369;[PDGFRB, ITK, PDGFRA, C5AR1, PTAFR, AVPR1A, SELE, RASGRP4, EDNRA, KIT, PLCG1]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[SERPINE1, MYLK, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PRKCE, PADI2, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, SIRT1, F3, TMEFF2, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, SULF1, COL3A1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, PHLDA2, SEMA6A, IGFBP5, IGFBP3, F2R, TPM1, ADAM9, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, CXCL12, PTPRC, PLXNB2, ITGB3, CYR61, DUSP10, EMILIN1, ITGA4, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4B, TIE1, KLF4, IL1RN, SPARC, LGALS3, IL1R1, ACTN4, MIF, SFRP2, IL23A, PFN1, EPHA2, CCR1, TNFSF14, PPBP, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, PTPRK, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, GAB1, CEACAM1, CEACAM6, IL1B, KIT, SGK1, GNAI2, PAK1, CXCR2, PDPN, MPP1, CD74, PODN, DLC1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, POSTN, VCL, C5AR1, STAP1, TGFB2, TGFB1, SELP, IL6, BMP2, NR4A3, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, DDX58, ARAP3, MMP9, DCN, FGR, GREM1, IFNG, LAMA4, LAMA3, THBS1, EGF, LAMB1, MAPK14, TEK]
GO:0050920;regulation of chemotaxis;5.0;0.536669693073893;0.5585758583978668;7.309409857546866;25.007338360703717;4.4540636485420615;8.369731097893864E-4;0.5180220339825032;[SEMA5B, SERPINE1, CXCL13, C3AR1, IL6R, PDGFRB, PDGFRA, SEMA6A, MIF, IL23A, PADI2, SUCNR1, C5AR1, FPR2, PLA2G7, KLRK1, PDGFD, STAP1, NCKAP1L, S100A14, ELANE, LYN, CCR1, TGFB1, TNFSF14, AZU1, PPBP, BST1, CXCL10, CXCL11, IL6, CXCL12, GPR18, ROBO2, NRP1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, MMP28, RAC2, CCR7, CCR6, CCR2, EDN1, F3, GREM1, IL1B, XCL1, CXCR4, THBS1, CCL7, CCL5, CXCR2, CCL4, NTF3, CCL2, CCL1, CCL19, JAM3, MPP1, CD74, CCL21, SEMA4B, MAPK14, PF4]
GO:0050921;positive regulation of chemotaxis;6.0;0.6417349323569144;0.6439877787686017;8.362857879160845;97.3409382187974;4.886724499458715;0.003257913601026301;0.5730276307483924;[NRP1, CXCL6, CXCL9, SERPINE1, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, C3AR1, RAC2, CCR7, CCR6, IL6R, CCR2, PDGFRB, EDN1, F3, IL23A, IL1B, XCL1, SUCNR1, C5AR1, FPR2, PLA2G7, THBS1, CCL7, CCL5, PDGFD, CXCR2, CCL4, NTF3, CCL1, NCKAP1L, CCL19, S100A14, CCR1, CD74, TGFB1, TNFSF14, CCL21, AZU1, PPBP, MAPK14, CXCL10, CXCL11, IL6, CXCL12, PF4]
GO:0048050;post-embryonic eye morphogenesis;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;48.05391351479887;7.9853141584524145;0.0016083212396259044;0.7314896500084853;[EFEMP1, MFAP2, FBN1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, CXCL10, CXCL11, IL6, BMP2, CXCL12, PTPRC, NR4A3, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0035583;sequestering of TGFbeta in extracellular matrix;9.0;1.0;0.896240625180289;9.628524252492122;582.4618396534061;8.67846133901236;0.019494473591576564;0.8400575416471059;[FBN1]
GO:0060981;cell migration involved in coronary angiogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;22.825287336738096;9.777073627680469;7.639418257356832E-4;0.8231203125901445;[PDGFRB]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[TGFB1, ABCB4, TNC, PTGS2, CXCL10, CD4, IL1B, SPP1, ALPL]
GO:0035582;sequestering of BMP in extracellular matrix;13.0;1.0;0.9625549647676366;9.628524252492122;807.9615809660012;8.390779266560578;0.027041746996717703;0.8916598066706847;[FBN1]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[SPARC, PTAFR, AQP9, SLC8A1, AQP1, THBD, JUN, IGFBP5, DUSP1, FOS, NME1, COL1A1, KCNQ1, NDUFS4, NOX4, SDC1, MMP19, FOSB, TEK, SLC26A3, CFTR]
GO:1903588;negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;10.0;1.0;0.9152410118609203;9.628524252492122;357.96927251473664;8.390779266560578;0.011980909399638815;0.8443458537639685;[THBS1]
GO:1903225;negative regulation of endodermal cell differentiation;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;302.8138100707639;8.67846133901236;0.010134905708332559;0.8188169164668168;[COL5A1, COL5A2]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[PYCARD, PPP2R1A, AKT1, EPHB2, MEN1, PAQR3, PRKCD, TSC2, SFRP2, PRKAR1B, THY1, SOCS2, FLRT2, PRKAR2B, SFN, LYN, CAV1, PLK1, NR2F2, PTPRC, PKIG, CDKN1A, LRRC4, TNFAIP3, PTPN22, HHEX, DUSP10, LRRTM4, NUP62, DUSP2, MYOCD, DUSP1, BGN, IRAK3, GP1BA, SIRT1, DUSP6, DCN, CEACAM1, IL1B, LRRC19, CDKN2C, PODN, PTPN6, PKN1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, RARA, ASCL2, NR1H2, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPB, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, IL1B, SATB2, CDX2, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, IRF7, FBP1, AURKB, SNCA, MEIS2]
GO:0030206;chondroitin sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;416.1007025877491;6.558197802812269;0.013926516049292044;0.7103865406232063;[BGN, DCN, VCAN, CSPG4]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[TGFB1I1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, IL1B, EZH2, ENG]
GO:1900747;negative regulation of vascular endothelial growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;326.5542293843208;8.16763571524637;0.01092947617776706;0.7686126355688037;[DCN]
GO:0030208;dermatan sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;665.197598747091;7.292166977892469;0.022263564991093197;0.747921758369865;[VCAN, BGN, CSPG4, DCN]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[, PID1, SERPINE1, SLA2, PHB2, STMN1, AKT1, HOMER3, UBASH3A, PRKACB, DAPK1, PRKCD, PADI2, PRKCQ, ATF3, GATA3, THY1, ADAMTS12, GATA1, FLRT2, FIGNL1, PRDM16, HMOX1, LYN, FZD1, SNAI2, EZH2, TGFB1I1, LRRC4, TIMP2, TIMP3, DUSP2, DUSP1, ARG1, FCRL3, BGN, PAWR, SIRT1, DUSP6, AES, MMP12, PXDN, LRRC19, PTGS2, FRZB, NR1H2, TMEM64, SULF1, SULF2, LGR4, PF4, TNF, CLU, PYCARD, RUVBL2, MEN1, TLE4, IGFBP5, IGFBP3, CSF1R, LY96, FOXO1, SOCS2, WFS1, TNFRSF10B, PTPRE, CXCL12, PTPRC, BCL6, BCL3, CCDC22, LRRK2, FASLG, PTPN22, HHEX, LBH, DUSP10, EMILIN1, PVRIG, CX3CR1, PPP1R15A, LRP1, LRP2, CCL5, FYN, CSK, CTHRC1, TIE1, KLF4, PTPN6, IL1RN, LGALS3, PPP2R1A, DHX58, EPHB2, EPHB1, IL1R2, PAQR3, MIF, RUNX2, SFRP4, SFRP2, SIK1, EPHA3, EPHA2, TWIST1, APCDD1, PKHD1, INPP5D, CD14, EGR1, LIF, VNN1, NRP1, PTPRR, ECM1, BRCA1, CD3E, RHOH, GP1BA, CEACAM1, BANK1, IL1B, KIT, TLR6, TLR4, YAP1, IFI6, GNAI2, CTNNA1, CD74, PODN, NLRP12, KIF26A, DLC1, FKBP1B, GRINA, RGS1, PDGFRB, PDGFRA, TSC2, HGS, HTRA1, FBLN1, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, CAV2, CAV1, ARHGAP25, NR4A2, NFKBIA, IL6, BMP2, FBN1, HMGB2, TNFAIP3, LRRTM4, NUP62, PTGIR, MYOCD, PLAUR, ARAP3, IRAK3, AXIN2, MMP9, DCN, DNM2, TGFBR3, GREM1, NDUFS3, FBP1, PFDN5, LTF, BCL2A1, CLEC12B, TAF9, THBS1, SNCA, EGF, MAPK14, TEK]
GO:0030207;chondroitin sulfate catabolic process;8.0;1.0;0.875;9.628524252492122;411.79540990145875;7.138016298065211;0.01378242177759377;0.7400384854347593;[VCAN, BGN, CSPG4, DCN]
GO:0045112;integrin biosynthetic process;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;39.16312370347755;9.777073627680469;0.0013107545058323288;0.7902410118609202;[COL5A1]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[NRP1, EDN1, PLXND1, IHH, EDNRA, SFRP2, COL4A1, ENG]
GO:0010952;positive regulation of peptidase activity;9.0;0.7140352122741334;0.7532582313173557;9.377209824211215;435.08389316762396;4.595290077388384;0.014561866354238107;0.6312439734407735;[TNF, ANTXR1, CTGF, PYCARD, SOX7, DAPK1, F2R, PCOLCE, SFRP2, IFI27, S100A8, PSMD14, FBLN1, NLRP3, LYN, CAV1, FN1, TNFRSF10B, FASLG, CYR61, CTSH, CR1, SIRT1, F3, ASPH, LCK, NLRC4, HSPD1, PERP, FYN, SNCA, CASP8AP2, GSN, HSPE1, MAPK14, PML, NLRP12, P2RX1, DLC1]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, SFN, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, TNFAIP8, SERPINA1, TIMP2, TIMP3, TIMP1, CR1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, LTF, SERPINB10, IFI6, NLRC4, PTGS2, THBS1, CST3, SPOCK3, SNCA, KLF4]
GO:0051901;positive regulation of mitochondrial depolarization;8.0;1.0;0.875;9.628524252492122;107.42585434118669;7.57984905034425;0.0035954466678074135;0.7626338329336335;[DCN]
GO:2000573;positive regulation of DNA biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.427853557029971;748.2879117532506;5.618190544320798;0.02504452299098255;0.6623145257091445;[AURKB, CCT8, CCT7, CCT5, CCT4, RFC5, PDGFRB, CCT3, CCT2, RFC3, RFC4, RFC2, KLF4, GRHL2, CCT6A, GREM1, NOX4, PRKCQ]
GO:0051918;negative regulation of fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;332.9628274369728;7.474488534686424;0.011143966187225523;0.7784863164434164;[THBD, SERPINE1, THBS1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, JUN, HACE1, NR2F2, EZH2, HOXC10, CHAF1B, FOS, SIRT1, STAT4, FLNA, ZNF467, CASP8AP2, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, CIITA, FHL2, FASLG, HHEX, BIRC5, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, FOXA3, FOXA2, LOXL2, HMGA1, MXD1, HMGB2, AFF3, LYL1, NUP62, MYOCD, ETV1, ELF3, IRF7, CREB5, TAF9, MAPK14, TAF5, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, SNAI2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, AEBP1, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPB, SMARCD3, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, SOX7, SOX4, EBF1, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, PURA, CDX2, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, COL4A2, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[, POP5, SPI1, SLA2, AKT1, PRKACB, CDCA3, PDGFA, GATA3, FN1, DUSP2, DUSP1, BGN, DUSP6, SPP1, IL12RB2, COL3A1, PKN1, EFEMP1, KCNH1, KCNH2, FBXW2, CDC25A, BLK, PKMYT1, NAE1, BMX, HM13, IL2RG, EIF4H, FYN, IL2RB, EIF3F, CDC20, HERC5, C1GALT1C1, LGALS1, TNFSF11, SNRPD3, ALG8, BTC, BTK, NAIP, EPB42, SDC2, EGR2, PTK2, MUC13, MUC15, SPTAN1, SYK, RNF144B, IL1B, KIT, PCNA, KITLG, NDUFAB1, BUB1B, LOXL1, LOXL2, UBE2C, UBE2M, FBN1, TNFAIP3, GHR, CAD, IRAK3, SHANK3, SPOCK3, TEK, PRKCE, PRKCD, HMBS, PRKCQ, PRDM16, ST3GAL6, IGHA1, BARD1, PLK2, PLK1, ASGR1, ASGR2, IFIH1, TIMP1, CIT, RARA, USP1, GSN, ELP4, NUCB1, TNC, IL5RA, TNF, FGF5, LAMP2, MAP2K2, VRK1, NRBP1, FKBP3, MAP2K6, COPS5, P4HA2, CCDC22, LAT, GAL3ST1, CYR61, LCK, TPTE, NLRC4, NOD2, TTR, CSK, PML, PPIL4, PPP2R1A, RPS6KA1, ESCO2, POR, SIK1, CFTR, LIF, PRL, GFRA3, ZDHHC17, HCK, TLR7, TLR4, TLR2, GUCY2C, CST3, QPCT, LOX, NLRP3, CBX4, EIF2S1, KDM5D, DCN, ZAP70, LTF, HIST1H2BK, THBS1, BUB1, SNCA, WEE1, EHMT2, MYLK, KRTCAP2, MEF2A, MEF2C, HSPG2, PRKAR1B, PADI2, SPARCL1, PADI4, UQCRC2, THY1, IQGAP3, LYN, ABCA1, HACE1, LYZ, EZH2, SIRT1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FSTL1, USP9Y, PSMC6, PSMC2, CCNT2, F13A1, RUVBL2, RUVBL1, AP2M1, S100A8, FOXO1, SOCS2, NFKB1, PTPRE, PTPRC, ST6GALNAC2, LRRK2, UTY, DSP, PPP1R12A, BIRC5, DTL, PPP1R15A, CCL8, CCL5, CCL2, NDUFA7, TIE1, PTPN6, CCNH, EPHB2, EPHB1, PAQR3, EREG, MXRA8, ALPK2, EPHA3, EPHA2, TF, PTPRR, FKBP14, SUV39H1, PTPRK, BRCA1, BRCA2, BMI1, CTSH, CTSG, CCR5, PDZRN3, PAK1, PRKY, PPP1CA, FKBP1B, GXYLT2, PDGFRB, PDGFRA, CCNE1, CALCA, KLHL14, PSMD14, PSEN2, RASGRP4, SPTA1, CCNB1, CLK4, CLK1, IL6, BMP2, LAMC1, MMP1, DDX58, MMP2, CCNA2, VCAN, TAF9, AURKB, GALNT7, GALNT6, EGF, LAMB1, MAPK14, TAF5, DAPK1, CDK14, ITK, SERPINA1, ANXA1, HBEGF, FAM105A, GTF2H1, CHRM1, ABHD12, GRAP2, MACROD2, STK32B, MEN1, IGFBP5, IGFBP3, MELK, CSF1R, CUL5, NACC2, IGFBP7, WFS1, MARCH3, MARCH1, CDK1, PTPN22, DUSP10, CHUK, ASPH, IL3RA, RNF24, CHEK1, SKP2, BCL11A, MAP4K1, B3GNT5, SGK1, RANBP2, CAMK4, CAMK1, GALNT14, ARID4A, ARID4B, FBL, APLP2, CSF2RB, ADRB2, TGFB2, TGFB1, NFKBIA, FES, TGFBI, TGFBR3, FGR, EHHADH, CAMK2D, NCAM1]
GO:0060857;establishment of glial blood-brain barrier;5.0;1.0;0.7902410118609202;9.628524252492122;66.94547054624944;9.777073627680469;0.0022406046521710444;0.7902410118609202;[MXRA8]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, PRKCE, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CD24, GPR18, CXCL9, FASLG, ADM, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, EDN1, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL21, GPR6, P2RX5, CD4, FKBP1B, F2RL3]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MEF2C, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, POU4F1, PF4, TNF, CLU, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, BCL3, CDK1, MYD88, LRRK2, FHL2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, CX3CR1, CEBPB, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, IL10, EDN1, FCER1G, HCK, RNF144B, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, LTF, BCL2A1, TAF9, DLL1, THBS1, AURKB, HSPD1, SNCA, TEK]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, ADM, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, PML, P2RX1, MNDA, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, LTBR]
